m+Medelevator.RU
← Поиск публикаций
Journal of controlled release : official journal of the Controlled Release Society · 2026

Engineering oral hydrogels for versatile drug delivery: core technologies, disease applications, and industrial translation.

СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Liu Dongyan, Guo Bei, Qin Fei, Cao Yilin, Zhong Jingfeng, Xie Zhoufan, Bao Yinxia, Lai Yecai, Guo Ruizhi, Liao Yiqiu, Jiang Jieqiong, Liu Mingwei, Zhou Guiling, Wu Chuanbin, Lu Chao, Zhang Yi, Xu Zejun

Аннотация

Oral drug delivery is preferred for patient compliance, but it's challenging for biologics and sensitive therapeutics due to the harsh gastrointestinal environment. Engineered oral hydrogels, enhanced through chemical modifications, offer superior entrapment efficiency and controlled release compared to traditional forms like capsules. Through innovative mechanisms, including stimuli-responsiveness, active adhesion, and microenvironmental modulation, oral hydrogels overcome key limitations associated with traditional oral formulations. These systems can achieve prolonged retention and site-specific controlled release in targeted areas of the gut, such as the colon, through chemical engineering strategies. Meanwhile, they can also be used as bioactive ingredients to regulate intestinal microbiota, restore the integrity of the mucosal barrier, and play a systemic therapeutic role in distal organs through the gut-brain axis and gut-immune axis. This review summarizes the research progress of oral hydrogel materials, focusing on their stimuli-responsive and mucus-adhesive designs for efficient drug delivery, as well as extended functions such as regulation of intestinal microbiota. It also addresses the challenges of clinical translation and examines bottlenecks and regulatory pathways to scale up through disease-specific cases. Finally, an integrated framework combining rational design, artificial intelligence, and translational science is proposed to bridge the gap from laboratory research to clinical applications.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты